Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Adenocarcinoma × Irinotecan × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 27 Pancreatic Neoplasms 12 Neuroblastoma 10 Stomach Neoplasms 9 Neoplasm Metastasis 9 Neoplasms 7 Rectal Neoplasms 5 Small Cell Lung Carcinoma 3 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Ovarian Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Colonic Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2 Sarcoma 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Biliary Tract Neoplasms 2 Advanced Solid Tumors 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Refractory Solid Tumors 1

Interventions

Gemcitabine 3 Radiotherapy, Intensity-Modulated 2 Albumin-Bound Paclitaxel 2 Taxes 1 S 1 (combination) 1 Radiotherapy 1 Panitumumab 1 Optical Imaging 1 Irinotecan 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06250972 2025-08-07

PTCA199-11

Fudan University

Phase 3 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡